Shan, Yilong <br/><br/>
The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke.  [electronic resource] 

 -  Journal of neuroinflammation  Nov 2019 
 - 242 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1742-2094 
<br/><br/><label>Standard No.: </label>10.1186/s12974-019-1638-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Astrocytes--drug effects<br/>Blood-Brain Barrier--drug effects<br/>Chemokine CCL2--metabolism<br/>Chemokine CXCL1--metabolism<br/>Exenatide--pharmacology<br/>Infarction, Middle Cerebral Artery--metabolism<br/>Inflammation--drug therapy<br/>Male<br/>Matrix Metalloproteinase 9--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Stroke--metabolism<br/>Vascular Endothelial Growth Factor A--metabolism<br/>Glucagon-Like Peptide-1 Receptor Agonists